please post the nejm article. thanks.
Troymister
Thursday, June 02, 2022 12:56:55 AM
Re: None
Post#
480850
of 480869
From today's (6/1) New York Times: Researchers have managed to tame pancreatic cancer in a woman whose cancer was far advanced and after other forms of treatment had failed. The experiment that helped her is complex and highly personalized and is not immediately applicable to most cancer patients. Another pancreatic cancer patient, who received the same treatment, did not respond and died of her disease.
Nonetheless, a leading journal — The New England Journal of Medicine — published a report of the study on Wednesday.
Dr. Eric Rubin, the journal’s editor in chief called the proof of concept experiment “an important step along the way” to devising similar treatments that might be applicable to lung, colon and other cancers.
The experiment involved genetically reprogramming the patient’s T cells, a type of white blood cell of the immune system, so they can recognize and kill cancer cells.
Recent NWBO News
Quarterly Report (10-q) • Edgar (US Regulatory) • 05/10/2022 10:02:07 AM
Amended Annual Report (10-k/a) • Edgar (US Regulatory) • 05/02/2022 09:05:06 PM
TNS Issues New Reports on Stocks with Potential Near Term Catalysts and a Feature Green Energy NASDAQ Report • InvestorsHub NewsWire • 04/12/2022 12:30:00 PM
TNS Feature Report and Next Gen Tech and Biotech That Could Change Our Lives • InvestorsHub NewsWire • 03/17/2022 12:00:00 PM
Seeking Alpha - ALYI sees substantial interest for new EV taxi program • InvestorsHub NewsWire • 03/04/2022 02:11:16 PM
Annual Report (10-k) • Edgar (US Regulatory) • 03/01/2022 05:49:59 PM
Northwest stock rises 9% as company
News 
Market Data 
Discover 
AI
